Stephen Hahn’s can­cer-test­ing biotech hires a new CMO; For­mer Io­vance ex­ec named CEO of Ob­sid­i­an

Flag­ship Pi­o­neer­ing’s blood can­cer test­ing start­up Har­bin­ger Health has brought in drug in­dus­try vet­er­an May Or­fali as its new chief med­ical of­fi­cer.

Or­fali will be charged with wrap­ping up a key clin­i­cal tri­al for Har­bin­ger’s test, work­ing close­ly with ex-FDA head Stephen Hahn, who be­came the biotech’s CEO in 2021 af­ter leav­ing the agency.

Or­fali has spent more than 25 years work­ing in the in­dus­try, in­clud­ing near­ly a decade at var­i­ous roles at Pfiz­er and most re­cent­ly as CMO of Sig­ilon Ther­a­peu­tics, an­oth­er Flag­ship com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER